Researchers found that there has been little attention paid to intervention to enhance treatment adherence in nonpsychotic major depression, so they outlined steps for engagement, retention, and adherence for these patients.
Patients with binge eating disorder and depressive symptoms reported executive functioning deficits, even though neuropsychological tests showed no significant differences in executive functioning between them and healthy controls.
An integrated collaborative care intervention resulted in modest improvements in weight loss and depressive symptoms in adults with obesity and depression.
The Food and Drug Administration (FDA) has approved Zulresso (brexanolone; Sage Therapeutics) injection for the treatment of postpartum depression in adult women, the first drug to be approved for this indication. Zulresso, an analogue of the endogenous human hormone allopregnanolone, is intended for continuous intravenous (IV) infusion over 2.5 days following a titration schedule. It…
Preventive strategies to reduce cannabis use among youth are needed, as adolescent cannabis consumption is associated with increased risk for depression and suicidal behavior later in life.
